Therapeutics News and Research

RSS
Better visualization of soft tissues using Toshiba's LCI

Better visualization of soft tissues using Toshiba's LCI

Sorrento Therapeutics merge with subsidiary of Quikbyte Software

Sorrento Therapeutics merge with subsidiary of Quikbyte Software

Medtronic to showcase cardiovascular product portfolio at TCT 2009

Medtronic to showcase cardiovascular product portfolio at TCT 2009

ITI seeks qualified residency sites for STAIR Scholarship Program

ITI seeks qualified residency sites for STAIR Scholarship Program

Wyeth and Ambrx collaborate to produce the next generation of biologic drugs

Wyeth and Ambrx collaborate to produce the next generation of biologic drugs

Jennerex raises funds through private placement for clinical development programs

Jennerex raises funds through private placement for clinical development programs

AMR finds 75 percent of hetastarch recipients underwent surgical procedures

AMR finds 75 percent of hetastarch recipients underwent surgical procedures

Resolvyx Pharmaceuticals receives U.S. patent for RX-10045

Resolvyx Pharmaceuticals receives U.S. patent for RX-10045

Metabasis Therapeutics receives notice letter from Nasdaq

Metabasis Therapeutics receives notice letter from Nasdaq

JPO to grant patent from the Tuschl III patent series

JPO to grant patent from the Tuschl III patent series

Notice of Allowance issued by PTO for OSI's EGFR drug

Notice of Allowance issued by PTO for OSI's EGFR drug

Phase I trial of NPC-1C to commence

Phase I trial of NPC-1C to commence

Juvaris BioTherapeutics completes first close on Series B equity financing

Juvaris BioTherapeutics completes first close on Series B equity financing

Rexahn to sign licensing and stock purchase agreements with Teva Pharmaceutical

Rexahn to sign licensing and stock purchase agreements with Teva Pharmaceutical

Griffin Securities' report features stem cell hypothesis of cancer

Griffin Securities' report features stem cell hypothesis of cancer

Components of insulin-control system can reset body's biological clock

Components of insulin-control system can reset body's biological clock

Insulin metabolism regulates body's internal clock

Insulin metabolism regulates body's internal clock

Nimotuzumab drug approved for Mexican distribution

Nimotuzumab drug approved for Mexican distribution

Intarcia's ITCA 650 phase 2 study in type 2 diabetes begins patient enrollment

Intarcia's ITCA 650 phase 2 study in type 2 diabetes begins patient enrollment

CI Index of ten leading cancer immunotherapy stocks increase by 58% in two months

CI Index of ten leading cancer immunotherapy stocks increase by 58% in two months

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.